Patricia LoRusso Selected Research

Patricia LoRusso Research Topics

Disease

91	Neoplasms (Cancer) 02/2024 - 01/2002
12	Fatigue 07/2023 - 04/2004
9	Breast Neoplasms (Breast Cancer) 02/2024 - 10/2006
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2015
9	Nausea 01/2022 - 04/2004
8	Disease Progression 02/2024 - 06/2010
7	Diarrhea 01/2020 - 03/2005
5	Thrombocytopenia (Thrombopenia) 12/2021 - 09/2011
5	Exanthema (Rash) 10/2020 - 02/2009
4	Vomiting 01/2022 - 04/2004
4	Melanoma (Melanoma, Malignant) 01/2020 - 01/2015
3	Adenocarcinoma 02/2024 - 07/2023
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 06/2015
3	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 04/2012
2	Triple Negative Breast Neoplasms 02/2024 - 02/2024
2	Colorectal Neoplasms (Colorectal Cancer) 07/2023 - 01/2023
2	Dehydration (Water Stress) 01/2022 - 01/2020
2	Neutropenia 12/2021 - 03/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 08/2017
2	Carcinogenesis 01/2021 - 02/2015
2	Uveal melanoma 01/2020 - 11/2019
2	Dysgeusia (Parageusia) 11/2019 - 06/2013
2	Anemia 11/2019 - 08/2017
2	Basal Cell Carcinoma (Rodent Ulcer) 07/2017 - 02/2015
2	Febrile Neutropenia 11/2015 - 09/2011
2	Hyperglycemia 07/2015 - 04/2004
2	Ewing Sarcoma (Sarcoma, Ewing) 05/2012 - 04/2011
2	Neoplasm Metastasis (Metastasis) 06/2006 - 11/2002
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2024
1	Hypoxia (Hypoxemia) 12/2023

Drug/Important Bio-Agent (IBA)

8	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 08/2017
8	Monoclonal AntibodiesIBA 07/2023 - 02/2013
8	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020 - 09/2013
6	olaparibIBA 02/2024 - 01/2018
6	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 09/2012
6	cobimetinibIBA 01/2021 - 01/2015
5	ErbB Receptors (EGF Receptor)IBA 07/2023 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2012
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 11/2015
4	Mitogen-Activated Protein KinasesIBA 10/2020 - 01/2015
4	Docetaxel (Taxotere)FDA Link 03/2016 - 10/2006
4	Lapatinib (GW572016)FDA Link 12/2013 - 03/2008
3	NivolumabIBA 02/2024 - 11/2021
3	atezolizumabIBA 12/2023 - 01/2019
3	veliparibIBA 01/2023 - 02/2010
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 08/2017
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 03/2013
3	Phosphotransferases (Kinase)IBA 01/2017 - 12/2015
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2015 - 01/2011
3	temsirolimus FDA Link 07/2015 - 09/2011
3	cixutumumabIBA 07/2015 - 09/2011
3	pazopanib FDA Link 07/2013 - 08/2012
3	Gemcitabine FDA Link 06/2010 - 02/2002
2	IpilimumabIBA 02/2024 - 11/2021
2	Hormones (Hormone)IBA 02/2024 - 01/2022
2	entinostat (MS 275)IBA 02/2024 - 11/2021
2	cediranib (AZD2171)IBA 02/2024 - 01/2018
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2024 - 01/2021
2	Ado-Trastuzumab EmtansineIBA 01/2024 - 09/2012
2	AntibodiesIBA 01/2024 - 01/2016
2	RamucirumabIBA 12/2023 - 10/2016
2	LigandsIBA 11/2023 - 01/2022
2	PlatinumIBA 09/2023 - 08/2017
2	Vorinostat FDA Link 08/2023 - 10/2010
2	BilirubinIBA 01/2022 - 07/2017
2	Alanine Transaminase (SGPT)IBA 01/2022 - 08/2017
2	Trastuzumab (Herceptin)FDA Link 12/2021 - 09/2012
2	Histone Deacetylase InhibitorsIBA 11/2021 - 10/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	ProdrugsIBA 01/2021 - 12/2011
2	ravoxertinibIBA 10/2020 - 01/2020
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 01/2017
2	binimetinibIBA 01/2020 - 01/2015
2	rucaparibIBA 01/2019 - 08/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2018 - 02/2002
2	Transaminases (Aminotransferases)IBA 01/2017 - 03/2016
2	AntigensIBA 01/2017 - 04/2012
2	taxaneIBA 03/2016 - 09/2012
2	navitoclaxIBA 11/2015 - 11/2015
2	Growth Factor ReceptorsIBA 07/2015 - 05/2012
2	Insulin-Like PeptidesIBA 07/2015 - 04/2011
2	Insulin (Novolin)FDA Link 07/2015 - 05/2012
2	TOR Serine-Threonine KinasesIBA 07/2015 - 04/2011
2	TabletsIBA 03/2015 - 08/2012
2	trametinibIBA 01/2015 - 09/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 12/2011
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2014 - 03/2013
2	SolventsIBA 12/2013 - 04/2012
2	human ERBB2 proteinIBA 09/2012 - 03/2008
2	Fluorouracil (Carac)FDA LinkGeneric 10/2006 - 04/2004
2	XK 469 (XK469)IBA 02/2002 - 02/2002
1	Circulating Tumor DNAIBA 02/2024
1	DHES0815AIBA 01/2024
1	trastuzumab deruxtecanIBA 01/2024

Therapy/Procedure

32	Therapeutics 02/2024 - 03/2005
4	Drug Therapy (Chemotherapy) 01/2024 - 03/2005
3	Immunotherapy 01/2024 - 03/2005
2	Oral Administration 06/2011 - 02/2010